Visceral leishmaniasis in India.
Bryceson
A
A
D000666:Amphotericin B / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007194:India; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D000666:Amphotericin B